310 related articles for article (PubMed ID: 9674936)
1. Neurobiology of lithium: an update.
Lenox RH; McNamara RK; Papke RL; Manji HK
J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
[TBL] [Abstract][Full Text] [Related]
2. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
3. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
5. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
6. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
7. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
8. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
Sela B
Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097
[TBL] [Abstract][Full Text] [Related]
9. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.
Manji HK; Lenox RH
Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897
[TBL] [Abstract][Full Text] [Related]
10. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
Manji HK; Chen G; Hsiao JK; Risby ED; Masana MI; Potter WZ
J Clin Psychiatry; 1996; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
Kilts CD
J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660
[TBL] [Abstract][Full Text] [Related]
12. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
McQuillin A; Rizig M; Gurling HM
Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
14. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
17. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
Fawcett JA
J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
[TBL] [Abstract][Full Text] [Related]
18. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness.
Lenox RH; Watson DG
Clin Chem; 1994 Feb; 40(2):309-14. PubMed ID: 8313612
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsants in bipolar disorder.
Singh V; Muzina DJ; Calabrese JR
Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
[TBL] [Abstract][Full Text] [Related]
20. The nature of bipolar disorder.
Manji HK; Lenox RH
J Clin Psychiatry; 2000; 61 Supp 13():42-57. PubMed ID: 11153812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
